EPITOPEA Trademark
Trademark Overview
On Thursday, February 29, 2024, a trademark application was filed for EPITOPEA with the United States Patent and Trademark Office. The USPTO has given the EPITOPEA trademark a serial number of 98426932. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 18, 2024. This trademark is owned by Epitopea Limited. The EPITOPEA trademark is filed in the Advertising, Business and Retail Services, Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical, medical or veterinary preparations and substances for the treatment of cancer and diseases of the immune system; Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; Compounds for treating cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer and diseases of the immune system for use in the fields of medicine, health, oncology, immunology; biological compounds or preparations for the treatment of cancer and diseases of the immune system; biological compounds or preparations for the prevention of cancer and diseases of the immune system; Therapeutic preparations for cancer and diseases of the immune system; Genetic markers for therapeutic or diagnostic use; Cells for medical use; pharmaceutical preparations for the prevention or treatment of tumors; Pharmaceutical preparations for activating cellular function; Cell growth ...
Compilation of statistical data relating to medical research for business purposes; Database management; Data processing; Data processing, systematization and management; Data processing services in the field of healthcare; Promoting public awareness of diseases, available medical treatments and disease prevention practices; Promoting public awareness of medical conditions, diagnosis of medical conditions and prevention of medical conditions; Consultancy and advisory services relating to all of the aforesaid services
Cells for scientific or research purposes; chemical substances for use in the manufacture of medicinal and pharmaceutical products; Chemicals, reagents and substances for medical research purposes; Immunoassay reagents, other than for medical or veterinary use; Chemicals for use in immuno-assay testing other than for medical or veterinary use; Immunoassays based on polypeptides for determining immunological profile, other than for medical or veterinary use; Diagnostic preparations and reagents for scientific or research use; Test kits consisting primarily of peptides, nucleic acids, buffers, and reagents for scientific or research use; Nucleic recombinant acids other than for medical or veterinary purposes; Nucleic acid sequencing programs, other than for medical or veterinary use; Chemical reagents for use in oncology research; Reagents for medical research; Diagnostic reagents, other than for medical or veterinary use; Cell culture reagents for scientific and research use; Biological...
Scientific research for medical purposes in the area of cancerous diseases; Research and development in the fields of oncology, and immunology; Research and development services in the fields of oncology and immunology research and development; Drug discovery; drug development; Medical and scientific research, namely, conducting clinical trials for others; Research relating to genetics; Research and development in the field of therapeutics; Research and development in the fields of biotechnology, pharmaceuticals, diagnostic preparations, vaccines, medicines, molecular sciences, clinical trials and therapeutics; Scientific laboratory services; Laboratory testing and analysis of materials; Biological research laboratory services; Services of a chemical laboratory; Development of biochemical reagents; Research and development of biological drug delivery platforms; Development of computer software, computing methods and algorithms; Computer programming; Database design; Online database mai...
General Information
| Serial Number | 98426932 |
| Word Mark | EPITOPEA |
| Filing Date | Thursday, February 29, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, November 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 10, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical, medical or veterinary preparations and substances for the treatment of cancer and diseases of the immune system; Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; Compounds for treating cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer and diseases of the immune system for use in the fields of medicine, health, oncology, immunology; biological compounds or preparations for the treatment of cancer and diseases of the immune system; biological compounds or preparations for the prevention of cancer and diseases of the immune system; Therapeutic preparations for cancer and diseases of the immune system; Genetic markers for therapeutic or diagnostic use; Cells for medical use; pharmaceutical preparations for the prevention or treatment of tumors; Pharmaceutical preparations for activating cellular function; Cell growth media for growing cells for medical use; Cellular function activating agents for medical purposes; Reconstituted cells for medical treatments; Preparations for detecting genetic predispositions for medical purposes; Pharmaceutical preparations for the prevention or treatment of immune system related diseases and disorders; Immunomodulators; Immunostimulants; Pharmaceutical preparations for immunity adjustment; Immunoassay reagents for medical use; Immunotherapeutic agents for use in treating bacterial infections; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Vaccines; Tumor antigens for medical use; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use; Biological compounds for use in the targeted pharmaceutical therapies; Proteins with diagnostic and therapeutic uses for medical use; Proteins for medical use; Diagnostic reagents for medical use; Reagents and substances for use in testing for medical purposes; Diagnostic and testing preparations for clinical, medical and medical laboratory use; Diagnostic and testing apparatus in the field of modulating therapeutics; Biomarkers for medical use; Nucleic acid sequences for medical purposes; Nucleic recombinant acids for medical use; Biological preparations and biological compounds for the treatment of cancer and diseases of the immune system; Biological reagents for medical use; Biological tissue cultures for medical purposes; Indicators for medical diagnosis; In vivo diagnostic scanning agents for medical use; Diagnostic agents for pharmaceutical or medical use; Diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of peptides, nucleic acids, buffers, and reagents, for medical purposes; Medical diagnostic test strips for use in the field of cancer and diseases of the immune system; Pharmaceutical preparations for the treatment of cancers |
| Goods and Services | Compilation of statistical data relating to medical research for business purposes; Database management; Data processing; Data processing, systematization and management; Data processing services in the field of healthcare; Promoting public awareness of diseases, available medical treatments and disease prevention practices; Promoting public awareness of medical conditions, diagnosis of medical conditions and prevention of medical conditions; Consultancy and advisory services relating to all of the aforesaid services |
| Goods and Services | Cells for scientific or research purposes; chemical substances for use in the manufacture of medicinal and pharmaceutical products; Chemicals, reagents and substances for medical research purposes; Immunoassay reagents, other than for medical or veterinary use; Chemicals for use in immuno-assay testing other than for medical or veterinary use; Immunoassays based on polypeptides for determining immunological profile, other than for medical or veterinary use; Diagnostic preparations and reagents for scientific or research use; Test kits consisting primarily of peptides, nucleic acids, buffers, and reagents for scientific or research use; Nucleic recombinant acids other than for medical or veterinary purposes; Nucleic acid sequencing programs, other than for medical or veterinary use; Chemical reagents for use in oncology research; Reagents for medical research; Diagnostic reagents, other than for medical or veterinary use; Cell culture reagents for scientific and research use; Biological preparations for use in cell cultures other than for medical or veterinary use; Substances for use in genetic probe assay kits, other than for medical or veterinary use; Antibodies for scientific purposes |
| Goods and Services | Scientific research for medical purposes in the area of cancerous diseases; Research and development in the fields of oncology, and immunology; Research and development services in the fields of oncology and immunology research and development; Drug discovery; drug development; Medical and scientific research, namely, conducting clinical trials for others; Research relating to genetics; Research and development in the field of therapeutics; Research and development in the fields of biotechnology, pharmaceuticals, diagnostic preparations, vaccines, medicines, molecular sciences, clinical trials and therapeutics; Scientific laboratory services; Laboratory testing and analysis of materials; Biological research laboratory services; Services of a chemical laboratory; Development of biochemical reagents; Research and development of biological drug delivery platforms; Development of computer software, computing methods and algorithms; Computer programming; Database design; Online database maintenance for others; Design and development of computer software for use with medical technology; Design and development of software for medical diagnostic or veterinary diagnostic purposes; Design and development of computer systems for data input, output, processing, display and storage; technical surveying; Analysis of technical data, namely, oncology and immunology data; Research relating to data processing; Provision of research information and data relating to medical and veterinary research and development; Scientific research in the field of oncology and immunology conducted using databases; Consultancy, information and advisory services relating to all of the aforesaid services |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 29, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 29, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Epitopea Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge 13354764
GB |
Trademark Events
| Event Date | Event Description |
| Thursday, February 29, 2024 | NEW APPLICATION ENTERED |
| Thursday, July 11, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 17, 2024 | ASSIGNED TO EXAMINER |
| Thursday, November 7, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 7, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 17, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 17, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 7, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 12, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
